JP2024515697A - 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 - Google Patents

再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 Download PDF

Info

Publication number
JP2024515697A
JP2024515697A JP2023564480A JP2023564480A JP2024515697A JP 2024515697 A JP2024515697 A JP 2024515697A JP 2023564480 A JP2023564480 A JP 2023564480A JP 2023564480 A JP2023564480 A JP 2023564480A JP 2024515697 A JP2024515697 A JP 2024515697A
Authority
JP
Japan
Prior art keywords
cell
cells
stem
progenitor
gene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023564480A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024515697A5 (cg-RX-API-DMAC10.html
Inventor
カルロス ツニガ-プルッカー,ジュアン
Original Assignee
サニーブルック リサーチ インスティチュート
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by サニーブルック リサーチ インスティチュート filed Critical サニーブルック リサーチ インスティチュート
Publication of JP2024515697A publication Critical patent/JP2024515697A/ja
Publication of JP2024515697A5 publication Critical patent/JP2024515697A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/30—Cellular immunotherapy characterised by the recombinant expression of specific molecules in the cells of the immune system
    • A61K40/32—T-cell receptors [TCR]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/42—Cancer antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/7051—T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/125—Stem cell factor [SCF], c-kit ligand [KL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2307—Interleukin-7 (IL-7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/26—Flt-3 ligand (CD135L, flk-2 ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023564480A 2021-04-23 2022-04-22 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法 Pending JP2024515697A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163178990P 2021-04-23 2021-04-23
US63/178,990 2021-04-23
PCT/CA2022/050622 WO2022221962A1 (en) 2021-04-23 2022-04-22 Stem cells comprising an unrearranged t cell receptor (tcr) gene locus and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2024515697A true JP2024515697A (ja) 2024-04-10
JP2024515697A5 JP2024515697A5 (cg-RX-API-DMAC10.html) 2025-04-30

Family

ID=83723544

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023564480A Pending JP2024515697A (ja) 2021-04-23 2022-04-22 再構成されていないt細胞受容体(tcr)遺伝子座を含む幹細胞及びその使用方法

Country Status (6)

Country Link
US (1) US20240209314A1 (cg-RX-API-DMAC10.html)
EP (1) EP4326856A4 (cg-RX-API-DMAC10.html)
JP (1) JP2024515697A (cg-RX-API-DMAC10.html)
CN (1) CN117480249A (cg-RX-API-DMAC10.html)
CA (1) CA3216417A1 (cg-RX-API-DMAC10.html)
WO (1) WO2022221962A1 (cg-RX-API-DMAC10.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3091158A1 (en) 2018-02-14 2019-08-22 Sunnybrook Research Institute Method for generating cells of the t cell lineage

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016010148A1 (ja) * 2014-07-18 2016-01-21 国立大学法人京都大学 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法
WO2018183823A1 (en) * 2017-03-31 2018-10-04 Hera Testing Laboratories, Inc. Novel immunodeficient rat for modeling human cancer

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016010148A1 (ja) * 2014-07-18 2016-01-21 国立大学法人京都大学 多能性幹細胞から免疫細胞療法用t細胞を誘導する方法
WO2018183823A1 (en) * 2017-03-31 2018-10-04 Hera Testing Laboratories, Inc. Novel immunodeficient rat for modeling human cancer

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RAQUEL GAGO-FUENTES ET AL.: "Normal development of mice lacking PAXX, the paralogue of XRCC4 and XLF", FEBS OPEN BIO., vol. 8, no. 3, JPN6026025062, 2018, pages 426 - 434, ISSN: 0005885707 *

Also Published As

Publication number Publication date
US20240209314A1 (en) 2024-06-27
CA3216417A1 (en) 2022-10-27
WO2022221962A1 (en) 2022-10-27
EP4326856A1 (en) 2024-02-28
CN117480249A (zh) 2024-01-30
EP4326856A4 (en) 2025-10-08

Similar Documents

Publication Publication Date Title
JP7560502B2 (ja) 多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
EP3612557B1 (en) Antigen-specific immune effector cells
JP2023507118A (ja) 治療のための操作された細胞
KR20180063333A (ko) 면역 세포로의 만능 줄기 세포의 지정된 분화 방법
CA3091136A1 (en) Method for producing low-antigenic cell
CN114292817A (zh) 从多能性干细胞诱导细胞免疫治疗用t细胞的方法
US20260097074A1 (en) Erythroid lineages derived from pluripotent cells
WO2022221962A1 (en) Stem cells comprising an unrearranged t cell receptor (tcr) gene locus and methods of use thereof
US20250368955A1 (en) B cell lineages derived from pluripotent cells
US20250332260A1 (en) Immune compatible cells for allogeneic cell therapies to cover global, ethnic, or disease-specific populations
US20080112933A1 (en) Methods and Compositions for Increasing Stem Cell Homing Using Gas Activators
HK40085019A (en) Genomic engineering of pluripotent cells
KR20250099776A (ko) 만능 줄기세포 유래 t 세포 집단 및 이의 전구체
HK1258739B (en) Genomic engineering of pluripotent cells
HK1258739A1 (zh) 多能细胞的基因组工程改造
EA046022B1 (ru) Антигенспецифические иммунные эффекторные клетки

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240507

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250421

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250421

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260616